demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 severe or critically
COVID 19 outpatients
SNG001 inhaled interferon beta ACTIV-2 SNG001

0 studies excluded by filtering options 1